EDNY Judge Brian Cogan recently addressed the False Claims Act public disclosure bar and original source rule in a decision based on a qui tam Relator’s claims that defendants marketed a test to measure the levels of a certain hormone knowing that the test was flawed. In United States ex rel. Patriarca v. Siemens Healthcare
More Posts
EDNY Decision Shows Breadth of Fraud Restitution Recoverable By Hospital For Mold-Contaminated Intravenous Bags
DOJ Memoranda Encourage Dismissal of Declined False Claims Act Cases and Prohibit Government Reliance on Noncompliance with Agency Guidance Theory of Liability
Angry Text Message Recipient Loses Court Challenge On Flu Shot Reminder
Second Circuit Vacates Conviction of Pharmaceutical Distributor on Advice-of-Counsel Defense
Medicaid Fraud Whistleblower Loses Bid To Keep His Name Out Of The Public Eye
Pharmacy Chain Not Required To Reasonably Accommodate Needle-Phobic Pharmacist
Second Circuit Accepts Appeal of False Claims Act First-To-File Issues
Second Circuit Sets False Claims Act Pleading Standard For Claim Information
Supreme Court Limitation on Forfeiture Will Impact Health Care Fraud Prosecutions
Subscribe: Subscribe via RSS